Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martina Zappa

Showing results (1-10 of 44) with videos related to

Pageof 5
Sort By:
European Journal of Internal Medicine|August 18, 2022
Knowing the new Omicron BA.2.75 variant ('Centaurus'): A simulation studyMartina Zappa, Paolo Verdecchia, Fabio Angeli
European Journal of Internal Medicine|October 27, 2023
Newer COVID-19 vaccines: Still lights and shadows?Fabio Angeli, Martina Zappa, Paolo Verdecchia
European Journal of Internal Medicine|October 18, 2023
Global burden of new-onset hypertension associated with severe acute respiratory syndrome coronavirus 2 infectionFabio Angeli, Martina Zappa, Paolo Verdecchia
European Journal of Internal Medicine|April 22, 2023
Is the competition between variants the end of severe acute respiratory syndrome coronavirus 2 pandemic? A journey from Wuhan to XBB.1.16Martina Zappa, Paolo Verdecchia, Fabio Angeli
European Journal of Internal Medicine|November 10, 2022
The new phase of pandemic: Are BA.2.75 and BQ.1 competitive variants? An in silico evaluationMartina Zappa, Paolo Verdecchia, Fabio Angeli
Journal of Cardiovascular Development and Disease|January 20, 2023
Rethinking the Role of the Renin-Angiotensin System in the Pandemic Era of SARS-CoV-2Fabio Angeli, Martina Zappa, Paolo Verdecchia
European Journal of Internal Medicine|April 2, 2023
Severe acute respiratory syndrome coronavirus 2 evolution: How mutations affect XBB.1.5 variantMartina Zappa, Paolo Verdecchia, Fabio Angeli
Giornale Italiano Di Cardiologia (2006)|November 27, 2023
[Gene therapy for hypertension: focus on zilebesiran]Fabio Angeli, Martina Zappa, Claudia Bartolini, et al.
European Journal of Internal Medicine|August 19, 2022
Structural evolution of severe acute respiratory syndrome coronavirus 2: Implications for adhesivity to angiotensin-converting enzyme 2 receptors and vaccinesMartina Zappa, Paolo Verdecchia, Antonio Spanevello, et al.
European Journal of Internal Medicine|September 10, 2023
The old and the new: The EG.5 ('Eris') sub-variant of CoronavirusMartina Zappa, Paolo Verdecchia, Andrea Andolina, et al.
Pageof 5

Showing results (1-10 of 44) with videos related to

Sort By:
Pageof 5
European Journal of Internal Medicine|August 18, 2022
Knowing the new Omicron BA.2.75 variant ('Centaurus'): A simulation studyMartina Zappa, Paolo Verdecchia, Fabio Angeli
European Journal of Internal Medicine|October 27, 2023
Newer COVID-19 vaccines: Still lights and shadows?Fabio Angeli, Martina Zappa, Paolo Verdecchia
European Journal of Internal Medicine|October 18, 2023
Global burden of new-onset hypertension associated with severe acute respiratory syndrome coronavirus 2 infectionFabio Angeli, Martina Zappa, Paolo Verdecchia
European Journal of Internal Medicine|April 22, 2023
Is the competition between variants the end of severe acute respiratory syndrome coronavirus 2 pandemic? A journey from Wuhan to XBB.1.16Martina Zappa, Paolo Verdecchia, Fabio Angeli
European Journal of Internal Medicine|November 10, 2022
The new phase of pandemic: Are BA.2.75 and BQ.1 competitive variants? An in silico evaluationMartina Zappa, Paolo Verdecchia, Fabio Angeli
Journal of Cardiovascular Development and Disease|January 20, 2023
Rethinking the Role of the Renin-Angiotensin System in the Pandemic Era of SARS-CoV-2Fabio Angeli, Martina Zappa, Paolo Verdecchia
European Journal of Internal Medicine|April 2, 2023
Severe acute respiratory syndrome coronavirus 2 evolution: How mutations affect XBB.1.5 variantMartina Zappa, Paolo Verdecchia, Fabio Angeli
Giornale Italiano Di Cardiologia (2006)|November 27, 2023
[Gene therapy for hypertension: focus on zilebesiran]Fabio Angeli, Martina Zappa, Claudia Bartolini, et al.
European Journal of Internal Medicine|August 19, 2022
Structural evolution of severe acute respiratory syndrome coronavirus 2: Implications for adhesivity to angiotensin-converting enzyme 2 receptors and vaccinesMartina Zappa, Paolo Verdecchia, Antonio Spanevello, et al.
European Journal of Internal Medicine|September 10, 2023
The old and the new: The EG.5 ('Eris') sub-variant of CoronavirusMartina Zappa, Paolo Verdecchia, Andrea Andolina, et al.
Pageof 5